Literature DB >> 8847426

Influence of carbon monoxide (CO) on the early course of acute myocardial infarction.

S Elsasser1, T Mall, M Grossenbacher, M Zuber, A P Perruchoud, R Ritz.   

Abstract

OBJECTIVE: To clarify the influence of an elevated carboxyhemoglobin (COHb) blood level on the course of acute myocardial infarction and to evaluate the administration of supplemental oxygen on the COHb level and the incidence of complications.
DESIGN: Prospective clinical study with randomized, unblinded intervention.
SETTING: Coronary Care Unit of a university hospital. PATIENTS: 78 consecutive patients with acute myocardial infarction. Excluded were patients with severe dyspnea, pulmonary edema or any other medical indication for supplemental oxygen therapy.
INTERVENTIONS: Randomized therapy with 41/min oxygen in 35 patients. MEASUREMENTS AND
RESULTS: COHb was measured at admission and 4 h later. The incidence of serious arrhythmias and the maximal creatine kinase (CK) values were recorded. In patients with initial COHb > or = 5%, there were significantly more arrhythmias and significantly higher maximal CK values than in those with normal COHb admission (89 vs 33%, p < 0.001; and 1897 +/- 1602 u/l vs 960 +/- 1097 u/l, p=0.05). This effect was seen only in patients with Q-wave infarction, not in those with non-Q-wave infarction. Supplemental oxygen had no effect on the incidence of arrhythmias.
CONCLUSIONS: We conclude that myocardial infarction patients with acute Q-wave infarction and increased COHb levels at admission suffer a more severe course of the disease. This outcome was not influenced by oxygen therapy. Whether this finding indicates a casual relationship and whether higher oxygen concentrations would favorably alter the course of acute myocardial infarction remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8847426     DOI: 10.1007/bf01704738

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  38 in total

1.  Effect of low-level carbon monoxide exposure on onset and duration of angina pectoris. A study in ten patients with ischemic heart disease.

Authors:  E W Anderson; R J Andelman; J M Strauch; N J Fortuin; J H Knelson
Journal:  Ann Intern Med       Date:  1973-07       Impact factor: 25.391

2.  Cigarette smoking and exposure to carbon monoxide.

Authors:  P J Lawther; B T Commins
Journal:  Ann N Y Acad Sci       Date:  1970-10-05       Impact factor: 5.691

3.  The effects of cigarette smoking on total body burden and excretion rates of carbon monoxide.

Authors:  S A Landaw
Journal:  J Occup Med       Date:  1973-03

4.  Myocardial and systemic responses to carboxyhemoglobin.

Authors:  S M Ayres; S Giannelli; H Mueller
Journal:  Ann N Y Acad Sci       Date:  1970-10-05       Impact factor: 5.691

5.  Association of the frequency of acute cardiorespiratory complaints with ambient levels of carbon monoxide.

Authors:  T L Kurt; R P Mogielnicki; J E Chandler
Journal:  Chest       Date:  1978-07       Impact factor: 9.410

6.  Production of arrhythmias by elevated carboxyhemoglobin in patients with coronary artery disease.

Authors:  D S Sheps; M C Herbst; A L Hinderliter; K F Adams; L G Ekelund; J J O'Neil; G M Goldstein; P A Bromberg; J L Dalton; M N Ballenger
Journal:  Ann Intern Med       Date:  1990-09-01       Impact factor: 25.391

7.  Carbon monoxide levels in cardiac patients in an urban emergency department.

Authors:  J B Leikin; S Vogel
Journal:  Am J Emerg Med       Date:  1986-03       Impact factor: 2.469

8.  Acute elevation of blood carboxyhemoglobin to 6% impairs exercise performance and aggravates symptoms in patients with ischemic heart disease.

Authors:  K F Adams; G Koch; B Chatterjee; G M Goldstein; J J O'Neil; P A Bromberg; D S Sheps
Journal:  J Am Coll Cardiol       Date:  1988-10       Impact factor: 24.094

9.  Effects of low-level carbon monoxide exposure on resting and exercise-induced ventricular arrhythmias in patients with coronary artery disease and no baseline ectopy.

Authors:  A L Hinderliter; K F Adams; C J Price; M C Herbst; G Koch; D S Sheps
Journal:  Arch Environ Health       Date:  1989 Mar-Apr

10.  Lack of effect of low levels of carboxyhemoglobin on cardiovascular function in patients with ischemic heart disease.

Authors:  D S Sheps; K F Adams; P A Bromberg; G M Goldstein; J J O'Neil; D Horstman; G Koch
Journal:  Arch Environ Health       Date:  1987 Mar-Apr
View more
  1 in total

1.  Plasma and whole blood clot strength measured by thrombelastography in patients treated with clopidogrel during acute coronary syndromes.

Authors:  Deshun Lu; Janelle Owens; Rolf P Kreutz
Journal:  Thromb Res       Date:  2013-08-03       Impact factor: 3.944

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.